Dr. Kevin Leco, PhD
Children’s Health Research Institute
Scientist, Molecular Genetics Program
Lawson Health Research Institute
Scientist, Children's Health Research Institute
University of Western Ontario
Associate Professor, Department of Physiology & Pharmacology
Contact Information
Tel: (519) 661-3008
Fax: (519) 661-3827
E-mail: Kevin.Leco@schulich.uwo.ca
Web: http://www.physpharm.med.uwo.ca/people/personnel.html
Brief Biography
Dr. Leco received his PhD in Pharmacology and Therapeutics from the
University of Calgary in 1994. He continued his research training in Calgary
for an additional two years until he accepted a Post Doctoral Fellowship
in Toronto under the supervision of Dr. R. Khokha, at the Ontario Cancer
Institute. Dr. Leco was appointed Assistant Professor in the Department
of Physiology & Pharmacology at The University of Western Ontario
in 1999.
Research Interests
• Cellular and molecular physiology
• Developmental biology
• Respiratory physiology
Research Activities
Dr. Leco’s laboratory focuses on extracellular matrix metabolism
during development and in disease states. Specifically, research is dedicated
to understanding the role of a class of extracellular matrix degradative
enzymes termed matrix metalloproteinases and their natural inhibitors,
the tissue inhibitors of metalloproteinases in embryo implantation into
the mother's womb, the embryonic development of internal organs such as
heart and lung and adult pathological processes such as emphysema and
heart disease. His research will provide fundamental answers on how extracellular
matrix remodelling impacts mammalian development and the progression of
two debilitating diseases.
Publications
- Martin, EL, McCaig, LA, Moyer, BZ, Pape, MC, Leco, KJ, Lewis, JF, and Veldhuizen RAW (2005). Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation and hyperoxia. Am J Physiol 289(2): L244-251.
- Fedak, PWM, Khokha, R, Weisel, RD, Smookler, D, Ohno, N, Watson, KH,
Verma, S, Leco, KJ, Mickle, DAG, Li, RK (2004). TIMP-3 Deficiency Induces
Cardiac Failure. Circulation 110(16): 2401 2409.
- Martin, EL, Moyer, BZ, Pape, MC, Starcher, B, *Leco, KJ and *Veldhuizen,
RA (2003). Negative impact of TIMP-3 null mutation on lung structure and
function in response to sepsis. Am J Physiology 285: L1222-L1232. *Co-senior
authors provided equal contribution to this study.
- Gill, SE, Pape, MC, Khokha, R, Watson, AJ and Leco, KJ (2003). A Null
Mutation for Tissue Inhibitor of Metalloproteinases-3 (Timp-3) Impairs
Murine Bronchiole Branching Morphogenesis. Dev Biol 261: 313-323.
- Jung, J-C, Leco, KJ, Edwards, DR and Fini, ME (2002). Role of matrix
metalloproteinases in thyroid hormone-induced tadpole tail resorption.
Developmental Dynamics 223: 402-413.
- Young, DA, Phillips, BW, Lundy, C, Nuttall, RM, ,Hogan, A, Schultz,
GA, Leco, KJ, Clark, IM and Edwards, DR (2002). Identification of an initiator-like
element essential for the expression of the tissue inhibitor of metalloproteinases-4
(Timp-4) gene. Biochem Journal 364(1): 89-99.
- Leco, KJ, Waterhouse, P, Sanchez, OH, Gowing, KLM, Poole, AR, Wakeham,
A, Mak, T and Khokha, R (2001). Spontaneous air space enlargement in the
lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).
J Clin Invest 108(6): 817-829. See also: commentary; J Clin Invest 108(6):
799-800 and the cover of J Clin Invest 108(6).
- Fata, JE, Leco, KJ, Youra, EB, Yu, HYE, Waterhouse, P, Murphy, G, Moorehead,
RA and Khokha, R (2001). Accelerated apoptosis in the TIMP-3 deficient
mammary gland. J Clin Invest 108(6): 831-841.
- Yeow, KM, Phillips, BW, Beaudry, PP, Leco, KJ, Murphy, G and Edwards,
DR. (2001). Expression of MMPs and TIMPs in mammalian cells. Methods Mol
Biol 151:181 9.
- Fata, JE, Ho, AT-V, Leco, KJ, Moorehead, RA, and Khokha, R (2000).
Cellular turnover and extracellular matrix remodelling in female reproductive
tissues: functions of metalloproteinases and their inhibitors. Cell Mol
Life Sci 57: 77-95. Note: all authors contributed equally to this manuscript.
|